Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Female Infertility Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Parenteral
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Female Infertility Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Ovarian Hyperstimulation Syndrome
1.3.3 Multiple-gestation Pregnancies
1.3.4 Multiple-birth Infants
1.3.5 Premature Labor
1.3.6 Low Birth Weight
1.3.7 Risk of Cesarean Delivery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Female Infertility Drugs Market Perspective (2018-2034)
2.2 Female Infertility Drugs Growth Trends by Region
2.2.1 Global Female Infertility Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Female Infertility Drugs Historic Market Size by Region (2018-2023)
2.2.3 Female Infertility Drugs Forecasted Market Size by Region (2024-2034)
2.3 Female Infertility Drugs Market Dynamics
2.3.1 Female Infertility Drugs Industry Trends
2.3.2 Female Infertility Drugs Market Drivers
2.3.3 Female Infertility Drugs Market Challenges
2.3.4 Female Infertility Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Female Infertility Drugs Players by Revenue
3.1.1 Global Top Female Infertility Drugs Players by Revenue (2018-2023)
3.1.2 Global Female Infertility Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Female Infertility Drugs Revenue
3.4 Global Female Infertility Drugs Market Concentration Ratio
3.4.1 Global Female Infertility Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Female Infertility Drugs Revenue in 2024
3.5 Female Infertility Drugs Key Players Head office and Area Served
3.6 Key Players Female Infertility Drugs Product Solution and Service
3.7 Date of Enter into Female Infertility Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Female Infertility Drugs Breakdown Data by Type
4.1 Global Female Infertility Drugs Historic Market Size by Type (2018-2023)
4.2 Global Female Infertility Drugs Forecasted Market Size by Type (2024-2034)
5 Female Infertility Drugs Breakdown Data by Application
5.1 Global Female Infertility Drugs Historic Market Size by Application (2018-2023)
5.2 Global Female Infertility Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Female Infertility Drugs Market Size (2018-2034)
6.2 North America Female Infertility Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Female Infertility Drugs Market Size by Country (2018-2023)
6.4 North America Female Infertility Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Female Infertility Drugs Market Size (2018-2034)
7.2 Europe Female Infertility Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Female Infertility Drugs Market Size by Country (2018-2023)
7.4 Europe Female Infertility Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Female Infertility Drugs Market Size (2018-2034)
8.2 Asia-Pacific Female Infertility Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Female Infertility Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Female Infertility Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Female Infertility Drugs Market Size (2018-2034)
9.2 Latin America Female Infertility Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Female Infertility Drugs Market Size by Country (2018-2023)
9.4 Latin America Female Infertility Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Female Infertility Drugs Market Size (2018-2034)
10.2 Middle East & Africa Female Infertility Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Female Infertility Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Female Infertility Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Detail
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Female Infertility Drugs Introduction
11.1.4 Allergan Plc Revenue in Female Infertility Drugs Business (2018-2023)
11.1.5 Allergan Plc Recent Development
11.2 Ferring BV
11.2.1 Ferring BV Company Detail
11.2.2 Ferring BV Business Overview
11.2.3 Ferring BV Female Infertility Drugs Introduction
11.2.4 Ferring BV Revenue in Female Infertility Drugs Business (2018-2023)
11.2.5 Ferring BV Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Female Infertility Drugs Introduction
11.3.4 Merck KGaA Revenue in Female Infertility Drugs Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Female Infertility Drugs Introduction
11.4.4 Novartis AG Revenue in Female Infertility Drugs Business (2018-2023)
11.4.5 Novartis AG Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Female Infertility Drugs Introduction
11.5.4 Sanofi Revenue in Female Infertility Drugs Business (2018-2023)
11.5.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Female Infertility Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Parenteral
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Female Infertility Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Female Infertility Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Female Infertility Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Female Infertility Drugs Market Share by Region (2018-2023)
Table 9. Global Female Infertility Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Female Infertility Drugs Market Share by Region (2024-2034)
Table 11. Female Infertility Drugs Market Trends
Table 12. Female Infertility Drugs Market Drivers
Table 13. Female Infertility Drugs Market Challenges
Table 14. Female Infertility Drugs Market Restraints
Table 15. Global Female Infertility Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Female Infertility Drugs Market Share by Players (2018-2023)
Table 17. Global Top Female Infertility Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Infertility Drugs as of 2024)
Table 18. Ranking of Global Top Female Infertility Drugs Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Female Infertility Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Female Infertility Drugs Product Solution and Service
Table 22. Date of Enter into Female Infertility Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Female Infertility Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Female Infertility Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Female Infertility Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Female Infertility Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Female Infertility Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Female Infertility Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Female Infertility Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Female Infertility Drugs Revenue Market Share by Application (2024-2034)
Table 32. North America Female Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Female Infertility Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Female Infertility Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Female Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Female Infertility Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Female Infertility Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Female Infertility Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Female Infertility Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Female Infertility Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Female Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Female Infertility Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Female Infertility Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Female Infertility Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Female Infertility Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Female Infertility Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. Allergan Plc Company Detail
Table 48. Allergan Plc Business Overview
Table 49. Allergan Plc Female Infertility Drugs Product
Table 50. Allergan Plc Revenue in Female Infertility Drugs Business (2018-2023) & (US$ Million)
Table 51. Allergan Plc Recent Development
Table 52. Ferring BV Company Detail
Table 53. Ferring BV Business Overview
Table 54. Ferring BV Female Infertility Drugs Product
Table 55. Ferring BV Revenue in Female Infertility Drugs Business (2018-2023) & (US$ Million)
Table 56. Ferring BV Recent Development
Table 57. Merck KGaA Company Detail
Table 58. Merck KGaA Business Overview
Table 59. Merck KGaA Female Infertility Drugs Product
Table 60. Merck KGaA Revenue in Female Infertility Drugs Business (2018-2023) & (US$ Million)
Table 61. Merck KGaA Recent Development
Table 62. Novartis AG Company Detail
Table 63. Novartis AG Business Overview
Table 64. Novartis AG Female Infertility Drugs Product
Table 65. Novartis AG Revenue in Female Infertility Drugs Business (2018-2023) & (US$ Million)
Table 66. Novartis AG Recent Development
Table 67. Sanofi Company Detail
Table 68. Sanofi Business Overview
Table 69. Sanofi Female Infertility Drugs Product
Table 70. Sanofi Revenue in Female Infertility Drugs Business (2018-2023) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Infertility Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Female Infertility Drugs Market Share by Type: 2024 VS 2034
Figure 3. Parenteral Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global Female Infertility Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Female Infertility Drugs Market Share by Application: 2024 VS 2034
Figure 8. Ovarian Hyperstimulation Syndrome Case Studies
Figure 9. Multiple-gestation Pregnancies Case Studies
Figure 10. Multiple-birth Infants Case Studies
Figure 11. Premature Labor Case Studies
Figure 12. Low Birth Weight Case Studies
Figure 13. Risk of Cesarean Delivery Case Studies
Figure 14. Female Infertility Drugs Report Years Considered
Figure 15. Global Female Infertility Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 16. Global Female Infertility Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Female Infertility Drugs Market Share by Region: 2024 VS 2034
Figure 18. Global Female Infertility Drugs Market Share by Players in 2024
Figure 19. Global Top Female Infertility Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Infertility Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Female Infertility Drugs Revenue in 2024
Figure 21. North America Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. North America Female Infertility Drugs Market Share by Country (2018-2034)
Figure 23. United States Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Female Infertility Drugs Market Share by Country (2018-2034)
Figure 27. Germany Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Female Infertility Drugs Market Share by Region (2018-2034)
Figure 35. China Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Japan Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. South Korea Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Southeast Asia Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. India Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Australia Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Female Infertility Drugs Market Share by Country (2018-2034)
Figure 43. Mexico Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Brazil Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Female Infertility Drugs Market Share by Country (2018-2034)
Figure 47. Turkey Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Saudi Arabia Female Infertility Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Allergan Plc Revenue Growth Rate in Female Infertility Drugs Business (2018-2023)
Figure 50. Ferring BV Revenue Growth Rate in Female Infertility Drugs Business (2018-2023)
Figure 51. Merck KGaA Revenue Growth Rate in Female Infertility Drugs Business (2018-2023)
Figure 52. Novartis AG Revenue Growth Rate in Female Infertility Drugs Business (2018-2023)
Figure 53. Sanofi Revenue Growth Rate in Female Infertility Drugs Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed